Dextrose And Sodium Chloride Injection, Solution
NDC Package 0264-7608-10
Package Information
Dextrose And Sodium Chloride injection is these intravenous solutions are indicated for use in adults and pediatric patients as sources of electrolytes, calories and water for hydration. This formulation utilizes a injection, solution delivery system. Marketed by B. Braun Medical Inc., this product is identified by NDC 0264-7608 and is authorized under FDA application NDA019631.
Identification & Billing
- RxCUI: 1794881 - dextrose 5 % / sodium chloride 0.2 % in 250 ML Injection
- RxCUI: 1794881 - 250 ML glucose 50 MG/ML / sodium chloride 2 MG/ML Injection
- RxCUI: 1794881 - 250 ML Glucose 50 MG/ML / NaCl 2 MG/ML Injection
- RxCUI: 1794881 - dextrose 5 % / sodium chloride 0.2 % per 250 ML Injection
- RxCUI: 1794886 - dextrose 5 % / sodium chloride 0.2 % in 500 ML Injection
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0264 - B. Braun Medical Inc.
- 0264-7608 - Dextrose And Sodium Chloride
- 0264-7608-10 - 24 CONTAINER in 1 CASE / 500 mL in 1 CONTAINER
- 0264-7608 - Dextrose And Sodium Chloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0264-7608). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0264-7608-10 identifies a specific commercial package of 24 container in 1 case / 500 ml in 1 container of Dextrose And Sodium Chloride, a human prescription drug labeled by B. Braun Medical Inc.. This injection, solution is formulated for intravenous use and contains dextrose, unspecified form; sodium chloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by B. Braun Medical Inc. on February 24, 1988. The current certification is valid through December 31, 2026.
How is this B. Braun Medical Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00264760810. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.